Net Loss Per Share

12 Months Ended

Dec. 31, 2023

NOTE 12 – NET LOSS PER SHARE

On October 1, 2022, 42,023,632 shares of the Company’s common stock, par value $0.001 per share, were distributed to the Former Parent’s stockholders of record as of September 21, 2022. This share amount is utilized for the calculation of basic and diluted earnings per share for all periods presented prior to the Separation and such shares are treated as issued and outstanding for purposes of calculating historical net loss per share. For periods prior to the Separation, it is assumed that there are no dilutive equity instruments as there were no Xperi stock-based awards outstanding prior to the Separation.

For periods subsequent to the Separation, actual outstanding shares are used to calculate both basic and diluted weighted-average number of common shares outstanding. Potentially dilutive common shares, such as common shares issuable upon exercise of stock options and vesting of restricted stock awards and units are typically reflected in the computation of diluted net income per share by application of the treasury stock method. Due to the net losses reported, these potentially dilutive securities were excluded from the computation of diluted net loss per share, since their effect would be anti-dilutive.

The following table sets forth the computation of basic and diluted shares (in thousands, except per share amounts):


	Year Ended December 31,
	2023			2022			2021
Numerator:
Net loss attributable to the Company - basic and diluted	$	(136,613	)	$	(757,484	)	$	(175,622	)
Denominator:
Weighted-average number of shares used to compute net loss per share attributable to the Company - basic and diluted		43,012			42,029			42,024
Net loss per share attributable to the Company - basic and diluted	$	(3.18	)	$	(18.02	)	$	(4.18	)

The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the periods presented (in thousands):


	Year Ended December 31,
	2023		2022
Stock options		106		146
Restricted stock units		7,067		4,604
ESPP		81		—
Total		7,254		4,750

Potentially dilutive shares for the year ended December 31, 2021 were not considered as there were no Xperi stock-based awards outstanding prior to the Separation.